← Back to 4503.TReportPortrait · background graphics on

SPZCOAstellas Pharma Inc. · 4503.TData at close 2026-08-19

Health Care · Tokyo · FYE 03-31 · Prices AT CLOSE 2026-08-19 (JPY)

Last JPY 2,337.00Day +1.15%Mkt cap $26.6BP/E (FY) 14.4×1Y +40.0%Off 52W high −14.0%Vol (1Y) 29.8%

Price2023-08-21 → 2026-08-19

4503.T close: JPY 2,258 on 2023-08-21 to JPY 2,337 on 2026-08-19.

Split-adj closes · 240 of 4,032 · price return

At a glance

Top-10 13F concentration100.0%

13F 2026-Q1

Key fundamentalsFY 2026

P/E (FY)14.4×

Sales (TTM)JPY 2.14T

Earnings (TTM)JPY 291.54B

ROE17.4%

Net margin13.6%

ROIC13.9%

Debt / equity0.31×

EPS growth 3Y44.2%

Sales growth 3Y12.1%

FY ratios · TTM sales/earnings (JPY)

Trailing returns

YTD+13.4%

1Y+40.0%

3Y+14.3%

5Y+48.5%

10Y+100.5%

Since incept. (ann.)+10.6%

Total return · from 2010-01-04

Risk

Ann. volatility (1Y)29.8%

Ann. volatility (3Y)27.9%

Sharpe (1Y)1.37

Sharpe (3Y)0.33

Max drawdown (1Y)−20.7%

Max drawdown (3Y)−39.4%

Beta (3Y vs SPY)−0.39

Daily returns, ann.

Top institutional holders13F 2026-Q1

Manager	Shares	Value	% sh out	QoQ
Pacer Advisors, Inc.	2.1M	$34M	—	+9.6%
PARADIGM ASSET MANAGEMENT CO LLC	5,100	$80,752	—	+0.0%

Δ vs 2025-Q4 · % of shares outstanding not shown: this is a non-US line and we hold no SEC form provenance for it, so we cannot show that its cover-page count is in the same instrument as the 13F holdings (ordinary shares vs depositary receipts). The count we hold for this line is 1,809,663,075 shares (as of 2026-03-31, source company_meta:unlabelled). An unverified basis is withheld rather than served possibly wrong by a depositary ratio. Holder share counts are shown as filed.

Latest reported quarters

No reported quarters on file for 4503.T.

Basis & disclosures

EOD closes · nothing imputed or averaged · absent “—”
As-of differs by block · 13F = US long, 45+d lag, LOWER bound
Not investment advice · no recommendation, price target or solicitation
EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology